282 related articles for article (PubMed ID: 12604525)
1. Alteration of Escherichia coli topoisomerase IV to novobiocin resistance.
Hardy CD; Cozzarelli NR
Antimicrob Agents Chemother; 2003 Mar; 47(3):941-7. PubMed ID: 12604525
[TBL] [Abstract][Full Text] [Related]
2. Crystal structures of Escherichia coli topoisomerase IV ParE subunit (24 and 43 kilodaltons): a single residue dictates differences in novobiocin potency against topoisomerase IV and DNA gyrase.
Bellon S; Parsons JD; Wei Y; Hayakawa K; Swenson LL; Charifson PS; Lippke JA; Aldape R; Gross CH
Antimicrob Agents Chemother; 2004 May; 48(5):1856-64. PubMed ID: 15105144
[TBL] [Abstract][Full Text] [Related]
3. Active-site residues of Escherichia coli DNA gyrase required in coupling ATP hydrolysis to DNA supercoiling and amino acid substitutions leading to novobiocin resistance.
Gross CH; Parsons JD; Grossman TH; Charifson PS; Bellon S; Jernee J; Dwyer M; Chambers SP; Markland W; Botfield M; Raybuck SA
Antimicrob Agents Chemother; 2003 Mar; 47(3):1037-46. PubMed ID: 12604539
[TBL] [Abstract][Full Text] [Related]
4. Contribution of the ATP binding site of ParE to susceptibility to novobiocin and quinolones in Streptococcus pneumoniae.
Dupont P; Aubry A; Cambau E; Gutmann L
J Bacteriol; 2005 Feb; 187(4):1536-40. PubMed ID: 15687222
[TBL] [Abstract][Full Text] [Related]
5. Accumulation of mutations in both gyrB and parE genes is associated with high-level resistance to novobiocin in Staphylococcus aureus.
Fujimoto-Nakamura M; Ito H; Oyamada Y; Nishino T; Yamagishi J
Antimicrob Agents Chemother; 2005 Sep; 49(9):3810-5. PubMed ID: 16127057
[TBL] [Abstract][Full Text] [Related]
6. Novel symmetric and asymmetric DNA scission determinants for Streptococcus pneumoniae topoisomerase IV and gyrase are clustered at the DNA breakage site.
Leo E; Gould KA; Pan XS; Capranico G; Sanderson MR; Palumbo M; Fisher LM
J Biol Chem; 2005 Apr; 280(14):14252-63. PubMed ID: 15659402
[TBL] [Abstract][Full Text] [Related]
7. Negative supercoiling of DNA by gyrase is inhibited in Salmonella enterica serovar Typhimurium during adaptation to acid stress.
Colgan AM; Quinn HJ; Kary SC; Mitchenall LA; Maxwell A; Cameron ADS; Dorman CJ
Mol Microbiol; 2018 Mar; 107(6):734-746. PubMed ID: 29352745
[TBL] [Abstract][Full Text] [Related]
8. Topoisomerase IV, not gyrase, decatenates products of site-specific recombination in Escherichia coli.
Zechiedrich EL; Khodursky AB; Cozzarelli NR
Genes Dev; 1997 Oct; 11(19):2580-92. PubMed ID: 9334322
[TBL] [Abstract][Full Text] [Related]
9. Mutations in topoisomerase IV and DNA gyrase of Staphylococcus aureus: novel pleiotropic effects on quinolone and coumarin activity.
Fournier B; Hooper DC
Antimicrob Agents Chemother; 1998 Jan; 42(1):121-8. PubMed ID: 9449271
[TBL] [Abstract][Full Text] [Related]
10. Analysis of topoisomerase function in bacterial replication fork movement: use of DNA microarrays.
Khodursky AB; Peter BJ; Schmid MB; DeRisi J; Botstein D; Brown PO; Cozzarelli NR
Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9419-24. PubMed ID: 10944214
[TBL] [Abstract][Full Text] [Related]
11. Differential behaviors of Staphylococcus aureus and Escherichia coli type II DNA topoisomerases.
Blanche F; Cameron B; Bernard FX; Maton L; Manse B; Ferrero L; Ratet N; Lecoq C; Goniot A; Bisch D; Crouzet J
Antimicrob Agents Chemother; 1996 Dec; 40(12):2714-20. PubMed ID: 9124828
[TBL] [Abstract][Full Text] [Related]
12. Distribution of gyrase and topoisomerase IV on bacterial nucleoid: implications for nucleoid organization.
Hsu YH; Chung MW; Li TK
Nucleic Acids Res; 2006; 34(10):3128-38. PubMed ID: 16757578
[TBL] [Abstract][Full Text] [Related]
13. Novobiocin Susceptibility of MukBEF-Deficient Escherichia coli Is Combinatorial with Efflux and Resides in DNA Topoisomerases.
Petrushenko ZM; Zhao H; Zgurskaya HI; Rybenkov VV
Antimicrob Agents Chemother; 2016 May; 60(5):2949-53. PubMed ID: 26926630
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of DNA gyrase and DNA topoisomerase IV of Staphylococcus aureus and Escherichia coli by aminocoumarin antibiotics.
Alt S; Mitchenall LA; Maxwell A; Heide L
J Antimicrob Chemother; 2011 Sep; 66(9):2061-9. PubMed ID: 21693461
[TBL] [Abstract][Full Text] [Related]
15. Contribution of mutations in DNA gyrase and topoisomerase IV genes to ciprofloxacin resistance in Escherichia coli clinical isolates.
Bansal S; Tandon V
Int J Antimicrob Agents; 2011 Mar; 37(3):253-5. PubMed ID: 21236644
[TBL] [Abstract][Full Text] [Related]
16. Topoisomerase IV is a target of quinolones in Escherichia coli.
Khodursky AB; Zechiedrich EL; Cozzarelli NR
Proc Natl Acad Sci U S A; 1995 Dec; 92(25):11801-5. PubMed ID: 8524852
[TBL] [Abstract][Full Text] [Related]
17. Novobiocin and coumermycin inhibit DNA supercoiling catalyzed by DNA gyrase.
Gellert M; O'Dea MH; Itoh T; Tomizawa J
Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4474-8. PubMed ID: 794878
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of inhibition of DNA gyrase by cyclothialidine, a novel DNA gyrase inhibitor.
Nakada N; Gmünder H; Hirata T; Arisawa M
Antimicrob Agents Chemother; 1994 Sep; 38(9):1966-73. PubMed ID: 7811004
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Neisseria gonorrhoeae Type II Topoisomerases by the Novel Spiropyrimidinetrione AZD0914.
Kern G; Palmer T; Ehmann DE; Shapiro AB; Andrews B; Basarab GS; Doig P; Fan J; Gao N; Mills SD; Mueller J; Sriram S; Thresher J; Walkup GK
J Biol Chem; 2015 Aug; 290(34):20984-20994. PubMed ID: 26149691
[TBL] [Abstract][Full Text] [Related]
20. Energy coupling in DNA gyrase and the mechanism of action of novobiocin.
Sugino A; Higgins NP; Brown PO; Peebles CL; Cozzarelli NR
Proc Natl Acad Sci U S A; 1978 Oct; 75(10):4838-42. PubMed ID: 368801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
